(LYRA) – Corporate News
-
Lyra Therapeutics (LYRA) Files $300M Mixed Shelf
-
Lyra Therapeutics (LYRA) Announces Positive Topline Results from BEACON Phase 2 Study of LYR-220
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to LYRA Stock Lookup